Zhan Siyan | 海南省真实世界数据研究院

Postgraduate Programs

Zhan Siyan

The dean of the School of Public Health and director of the department of epidemiology and health statistics of Peking University, director of the Clinical Epidemiology Research Center of Peking University Third Hospital (double employed), director of the Smart Public Health Research Center, the Research Institute of Artificial Intelligence of Peking University, deputy director of the Center for Evidence-based Medicine, Peking University, director of the Post-marketing Drug Safety Research Center, the Department of Medical Science, Peking University. At present, she serves as an executive member of the Chinese Pharmaceutical Association, director of the Pharmacoepidemiology Board, director of the Epidemiology branch of the China Preventive Medicine Association, deputy director of Public Health Education branch and deputy director of the Evidence-based Preventive Medicine Board, an expert with the 8th Discipline Evaluation Group (Public Health and Preventive Medicine) of the Academic Degrees Committee of the State Council, a member of the Expert Advisory Committee of Drug Registration and Evaluation (Expert Advisory Committee of Drug Safety and Risk Management) and the Expert Advisory Committee of National Immunization Planning.

【Scientific Prowess】

In recent years, she has undertaken several programs funded by the Ministry of Science and Technology and National Natural Science Foundation, and won as the primary person-in-charge a third prize for progress in science and technology from the China Preventive Medicine Association (2013), a third prize for science and technology from the Chinese Pharmaceutical Association (2013), a third prize for progress in science and technology of Beijing (2013) and a second prize for scientific achievements of China (2013). In 2016, she won a prize in the 17th Wu Jieping-Paul Jasson Medical & Pharmaceutical Award. In 2017, she won a title of excellent teachers in Beijing. In 2020, she was honored as an excellent Party affairs worker of the Education Work Committee of Beijing. In 2020, she was selected as an advanced individual for the fight against the Covid-19 pandemic in Beijing and enjoyed the special allowance from the State Council. In 2021, as a chief compiler of textbooks, she won a second prize in the first National Textbook Construction Award and a nomination for a special prize of Baosteel for excellent teachers.

【Representative Programs】

[1] A general program funded by National Natural Science Foundation, the Strategic and Empirical Studies to Identify and Control the Time Correlation Bias in Pharmacoepidemiology, 2020-2023

[2] Gates Foundation funded program, The Real-world Study of Pharmacovigilance, 2021-2025

[3] National Key Research Program, Methodological Study of Standardization and Quality Control of Respiratory Disease Cohort, 2016-2021

[4] A major program funded by National Natural Science Foundation, the Study on Construction and Optimization of the Multi-mode and Multi-view Unreasonable Prescription Identification Model Based on Clinical Big Data, 2017-2019

[5] A general program funded by National Natural Science Foundation, Research on Active Monitoring Method of MDR-TB Drug Treatment Based on Universal Data Model, 2015-2018

[6] Beijing Science and Technology Program, Study on Monitoring of Adverse Reactions of Common Cardiovascular Drugs, 2015-2018

[7] A key program funded by Beijing Natural Science Foundation, Study on Genomic Epidemiology of Drug-induced Liver Damage in Anti-TB Treatment Cohort Population, 2011-2013

[8] A general program funded by National Natural Science Foundation, Study on Drug Metabolizing Enzyme Gene Polymorphism and the Genetic Susceptibility of Anti-TB Drugs, 2008-2010

[9] WHO China Health Policy Support Program, Policy Research on Chinese Drug Safety Evaluation Index System, 2008-2009

[10] Global Fund Project, Study on Adverse Anti-TB Drug Reactions in Chinese TB Control Plan, 2007-2009

【Academic Achievements】

[1] Zhao H, Wei L, Li H, Zhang M, Cao B, Bian J, Zhan S. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis. 2021 Jun;21(6):847-857.

[2] Sun Y, Zhang L, Li N, Zhao H, Ma R, Fang T, Yang T, Xu G, Liu Z, Zhan S. No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study. Expert Rev Vaccines. 2021 Dec 3:1-10.

[3] Liu Z, Meng R, Yang Y, Li K, Yin Z, Ren J, Shen C, Feng Z, Zhan S. Progress of Active Surveillance for Vaccine Safety in China. China CDC Wkly. 2021 Jul 2;3(27):581-583.

[4] Sun Y, Pei Z, Zhao H, Li L, Hu Y, Zhang L, Wang L, Yang Y, Huang T, Zhan S; China Cohort Consortium study group. Data Resource Profile: China Cohort Consortium (CCC). Int J Epidemiol. 2020 Oct 1;49(5):1436-1436m.

[1] Zhang C, Feng J, Wang S, Gao P, Xu L, Zhu J, Jia J, Liu L, Liu G, Wang J, Zhan S, Song C. Incidence of and trends in hip fracture among adults in urban China: A nationwide retrospective cohort study. PLoS Med. 2020 Aug 6;17(8):e1003180.

【Research Orientations】

1. Pharmacoepidemiology

2. Clinical epidemiology and evidence-based medicine

【Enrollment Majors】Biomedical engineering

【Contact Information】siyan-zhan@bjmu.edu.cn